Bioartificial Liver Therapy Using Chemically Induced Pluripotent Stem Cells in Liver Failure
Liver Failure
Enrolment: 12 · Results not recorded
Biologic · Cell therapy (iPS-derived hepatocyte-like cells); not a ChEMBL entity
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Liver Failure
Enrolment: 12 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute liver injury from a single intraperitoneal dose of carbon tetrachloride in mineral oil at 0.35 microlitres per gram; a repetitive injury model gave carbon tetrachloride at 0, 24 and 48 hours for the 72 hour survival study
Intravenous iPS reduced serum ALT and AST at 24 and 36 hours, cut necrotic area by about 40 per cent, more than doubled proliferating hepatocytes at 48 hours and raised hepatic IP-10, whereas iHL lowered transaminases but did not significantly reduce necrosis. Recombinant IP-10 reproduced the prote…
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.